These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


129 related items for PubMed ID: 2846575

  • 1. Solubilization of the active vasoactive intestinal peptide receptor from human colonic adenocarcinoma cells.
    el Battari A, Martin JM, Luis J, Pouzol O, Secchi J, Marvaldi J, Pichon J.
    J Biol Chem; 1988 Nov 25; 263(33):17685-9. PubMed ID: 2846575
    [Abstract] [Full Text] [Related]

  • 2. Molecular identification and structural requirement of vasoactive intestinal peptide (VIP) receptors in the human colon adenocarcinoma cell line, HT-29.
    Couvineau A, Rousset M, Laburthe M.
    Biochem J; 1985 Oct 01; 231(1):139-43. PubMed ID: 2998337
    [Abstract] [Full Text] [Related]

  • 3. Characterization and solubilization of vasoactive intestinal peptide receptors from rat lung membranes.
    Provow S, Veliçelebi G.
    Endocrinology; 1987 Jun 01; 120(6):2442-52. PubMed ID: 3032591
    [Abstract] [Full Text] [Related]

  • 4. Characterization of receptors for vasoactive intestinal peptide solubilized from the lung.
    Paul S, Said SI.
    J Biol Chem; 1987 Jan 05; 262(1):158-62. PubMed ID: 3025200
    [Abstract] [Full Text] [Related]

  • 5. Covalent cross-linking of vasoactive intestinal peptide (VIP) to its receptor in intact colonic adenocarcinoma cells in culture (HT 29).
    Muller JM, Luis J, Fantini J, Abadie B, Giannellini F, Marvaldi J, Pichon J.
    Eur J Biochem; 1985 Sep 02; 151(2):411-7. PubMed ID: 2992966
    [Abstract] [Full Text] [Related]

  • 6. Solubilization of rat lung vasoactive intestinal peptide receptors in the active state. Characterization of the binding properties and comparison with membrane-bound receptors.
    Patthi S, Simerson S, Veliçelebi G.
    J Biol Chem; 1988 Dec 25; 263(36):19363-9. PubMed ID: 2848823
    [Abstract] [Full Text] [Related]

  • 7. A human melanoma-derived cell line (IGR39) with a very high number of vasoactive-intestinal-peptide (VIP) receptors. 1. Molecular characterization of the binding site.
    Luis J, Martin JM, el Battari A, Reynier M, Marvaldi J, Pichon J.
    Eur J Biochem; 1989 Mar 15; 180(2):429-33. PubMed ID: 2538330
    [Abstract] [Full Text] [Related]

  • 8. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells.
    Gespach C, Bawab W, de Cremoux P, Calvo F.
    Cancer Res; 1988 Sep 15; 48(18):5079-83. PubMed ID: 2842044
    [Abstract] [Full Text] [Related]

  • 9. Simultaneous solubilization of high-affinity receptors for VIP and glucagon and of a low-affinity binding protein for VIP, shown to be identical to calmodulin.
    Andersson M, Carlquist M, Maletti M, Marie JC.
    FEBS Lett; 1993 Feb 22; 318(1):35-40. PubMed ID: 8382169
    [Abstract] [Full Text] [Related]

  • 10. Characterization of vasoactive intestinal peptide receptors in rat seminal vesicle.
    Guijarro LG, Rodriguez-Pena MS, Prieto JC.
    Am J Physiol; 1991 Feb 22; 260(2 Pt 1):E286-91. PubMed ID: 1847588
    [Abstract] [Full Text] [Related]

  • 11. Solubilization of the liver vasoactive intestinal peptide receptor. Hydrodynamic characterization and evidence for an association with a functional GTP regulatory protein.
    Couvineau A, Amiranoff B, Laburthe M.
    J Biol Chem; 1986 Nov 05; 261(31):14482-9. PubMed ID: 3021741
    [Abstract] [Full Text] [Related]

  • 12. Hydrodynamic characterization of vasoactive intestinal peptide receptors extracted from rat lung membranes in Triton X-100 and n-octyl-beta-D-glucopyranoside.
    Patthi S, Akong M, Veliçelebi G.
    J Biol Chem; 1987 Nov 15; 262(32):15740-5. PubMed ID: 2824466
    [Abstract] [Full Text] [Related]

  • 13. Characterization of receptors for VIP on pancreatic acinar cell plasma membranes using covalent cross-linking.
    McArthur KE, Wood CL, O'Dorisio MS, Zhou ZC, Gardner JD, Jensen RT.
    Am J Physiol; 1987 Mar 15; 252(3 Pt 1):G404-12. PubMed ID: 2435170
    [Abstract] [Full Text] [Related]

  • 14. Molecular characteristics and peptide specificity of vasoactive intestinal peptide receptors from rat cerebral cortex.
    Couvineau A, Gammeltoft S, Laburthe M.
    J Neurochem; 1986 Nov 15; 47(5):1469-75. PubMed ID: 3020175
    [Abstract] [Full Text] [Related]

  • 15. Solubilization of active and stable receptors for vasoactive intestinal peptide from rat liver.
    Guijarro L, Couvineau A, Calvo JR, Laburthe M.
    Regul Pept; 1989 Apr 15; 25(1):37-50. PubMed ID: 2541470
    [Abstract] [Full Text] [Related]

  • 16. Vasoactive intestinal peptide receptor on liver plasma membranes: solubilization and cross-linking.
    Nguyen TD, Kaiser LM.
    Peptides; 1990 Apr 15; 11(6):1255-61. PubMed ID: 1965036
    [Abstract] [Full Text] [Related]

  • 17. Cycloheximide induces accumulation of vasoactive intestinal peptide (VIP) binding sites at the cell surface of a human colonic adenocarcinoma cell line (HT29-D4). Evidence for the presence of an intracellular pool of VIP receptors.
    Luis J, Martin JM, el Battari A, Fantini J, Giannellini F, Marvaldi J, Pichon J.
    Eur J Biochem; 1987 Sep 01; 167(2):391-6. PubMed ID: 3040409
    [Abstract] [Full Text] [Related]

  • 18. Characterization of vasoactive intestinal peptide receptors on rat alveolar macrophages.
    Sakakibara H, Shima K, Said SI.
    Am J Physiol; 1994 Sep 01; 267(3 Pt 1):L256-62. PubMed ID: 7943252
    [Abstract] [Full Text] [Related]

  • 19. Evidence for vasoactive intestinal peptide receptors in apical membranes from tracheal epithelium.
    Elgavish A, Pillion DJ, Meezan E.
    Life Sci; 1989 Sep 01; 44(15):1037-42. PubMed ID: 2538697
    [Abstract] [Full Text] [Related]

  • 20. Photoaffinity labelling of the vasoactive-intestinal-peptide-binding site on intact human colonic adenocarcinoma cell line HT29-D4. Synthesis and use of photosensitive vasoactive-intestinal-peptide derivatives.
    Martin JM, Darbon H, Luis J, el Battari A, Marvaldi J, Pichon J.
    Biochem J; 1988 Mar 15; 250(3):679-85. PubMed ID: 2839143
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.